Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20862645rdf:typepubmed:Citationlld:pubmed
pubmed-article:20862645lifeskim:mentionsumls-concept:C0013216lld:lifeskim
pubmed-article:20862645lifeskim:mentionsumls-concept:C1457887lld:lifeskim
pubmed-article:20862645lifeskim:mentionsumls-concept:C0035168lld:lifeskim
pubmed-article:20862645lifeskim:mentionsumls-concept:C0036341lld:lifeskim
pubmed-article:20862645lifeskim:mentionsumls-concept:C0205160lld:lifeskim
pubmed-article:20862645lifeskim:mentionsumls-concept:C0032893lld:lifeskim
pubmed-article:20862645pubmed:issue9lld:pubmed
pubmed-article:20862645pubmed:dateCreated2010-9-23lld:pubmed
pubmed-article:20862645pubmed:abstractTextNegative symptoms in patients with schizophrenia predict a worse social outcome. The treatment options for negative symptoms are extremely limited. Various treatment strategies have been studied in which several types of medication were added to antipsychotics in order to alleviate negative symptoms.lld:pubmed
pubmed-article:20862645pubmed:languagedutlld:pubmed
pubmed-article:20862645pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20862645pubmed:citationSubsetIMlld:pubmed
pubmed-article:20862645pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20862645pubmed:statusMEDLINElld:pubmed
pubmed-article:20862645pubmed:issn0303-7339lld:pubmed
pubmed-article:20862645pubmed:authorpubmed-author:ArendsJJlld:pubmed
pubmed-article:20862645pubmed:authorpubmed-author:SlooffC JCJlld:pubmed
pubmed-article:20862645pubmed:authorpubmed-author:KnegteringHHlld:pubmed
pubmed-article:20862645pubmed:authorpubmed-author:JiawanV C RVClld:pubmed
pubmed-article:20862645pubmed:issnTypePrintlld:pubmed
pubmed-article:20862645pubmed:volume52lld:pubmed
pubmed-article:20862645pubmed:ownerNLMlld:pubmed
pubmed-article:20862645pubmed:authorsCompleteYlld:pubmed
pubmed-article:20862645pubmed:pagination627-37lld:pubmed
pubmed-article:20862645pubmed:meshHeadingpubmed-meshheading:20862645...lld:pubmed
pubmed-article:20862645pubmed:meshHeadingpubmed-meshheading:20862645...lld:pubmed
pubmed-article:20862645pubmed:meshHeadingpubmed-meshheading:20862645...lld:pubmed
pubmed-article:20862645pubmed:meshHeadingpubmed-meshheading:20862645...lld:pubmed
pubmed-article:20862645pubmed:meshHeadingpubmed-meshheading:20862645...lld:pubmed
pubmed-article:20862645pubmed:meshHeadingpubmed-meshheading:20862645...lld:pubmed
pubmed-article:20862645pubmed:year2010lld:pubmed
pubmed-article:20862645pubmed:articleTitle[Pharmacological treatment of negative symptoms in schizophrenia; research and practice].lld:pubmed
pubmed-article:20862645pubmed:affiliationUniversitair Centrum Psychiatrie, Groningen. v.c.r.jiawan@psy.umcg.nllld:pubmed
pubmed-article:20862645pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:20862645pubmed:publicationTypeEnglish Abstractlld:pubmed
pubmed-article:20862645pubmed:publicationTypeReviewlld:pubmed